It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dietary emulsifiers carboxylmethylcellulose (CMC) and polysorbate 80 (P80) alter the composition of the intestinal microbiota and induce chronic low-grade inflammation, ultimately leading to metabolic dysregulations in mice. As both gut microbiota and intestinal health can influence social and anxiety-like behaviors, we investigated whether emulsifier consumption would detrimentally influence behavior. We confirmed that emulsifier exposure induced chronic intestinal inflammation, increased adiposity, and altered gut microbiota composition in both male and female mice, although the specific microboal taxa altered following emulsifier consumption occurred in a sex-dependent manner. Importantly, emulsifier treatment altered anxiety-like behaviors in males and reduced social behavior in females. It also changed expression of neuropeptides implicated in the modulation of feeding as well as social and anxiety-related behaviors. Multivariate analyses revealed that CMC and P80 produced distinct clustering of physiological, neural, and behavioral effects in male and female mice, suggesting that emulsifier treatment leads to a syndrome of sex-dependent changes in microbiota, physiology, and behavior. This study reveals that these commonly used food additives may potentially negatively impact anxiety-related and social behaviors and may do so via different mechanisms in males and females.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Georgia State University, Neuroscience Institute, Atlanta, USA (GRID:grid.256304.6) (ISNI:0000 0004 1936 7400); School of Psychology, Georgia Institute of Technology, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)
2 Georgia State University, Neuroscience Institute, Atlanta, USA (GRID:grid.256304.6) (ISNI:0000 0004 1936 7400)
3 Georgia State University, Institute for Biomedical Sciences, Atlanta, USA (GRID:grid.256304.6) (ISNI:0000 0004 1936 7400)
4 Georgia State University, Neuroscience Institute, Atlanta, USA (GRID:grid.256304.6) (ISNI:0000 0004 1936 7400); Georgia State University, Institute for Biomedical Sciences, Atlanta, USA (GRID:grid.256304.6) (ISNI:0000 0004 1936 7400)